Related Experiment Videos

Antimutagenic activity of fluphenazine in short-term tests

K Gasiorowski1, B Brokos, K Szyba

  • 1Department of Basic Medical Sciences, Wrocłlaw Medical University, 14 Kochanowskiego Str., 51-601 Wrocłlaw, Poland. kaz@basmed.am.wroc.pl

Mutagenesis
|January 6, 2001
PubMed

Insights

Fluphenazine, an antipsychotic, demonstrated antimutagenic properties by reducing genotoxicity in various tests. This phenothiazine derivative also lowered free radical levels, suggesting a key mechanism for its protective effects against mutagens.

Area of Science:

  • Pharmacology
  • Genetics
  • Toxicology

Background:

  • Fluphenazine is a phenothiazine antipsychotic.
  • Genotoxicity is a major concern in drug development and exposure.
  • Understanding drug mechanisms against mutagens is crucial.

Purpose of the Study:

  • To evaluate the antimutagenic potential of fluphenazine.
  • To investigate the effect of fluphenazine on genotoxicity induced by various mutagens.
  • To explore the role of free radical reduction in fluphenazine's action.

Main Methods:

  • Ames test with direct and indirect mutagens.
  • Short-term tests on human lymphocytes (micronucleus assay, thioguanine resistance, sister chromatid exchange).
  • In vitro assessment of free radical levels in human granulocytes.

Main Results:

  • Fluphenazine reduced genotoxicity in the Ames test.
  • The strongest inhibitory effects were observed in the micronucleus assay and thioguanine resistance test.
  • Fluphenazine significantly decreased free radical levels in human granulocytes.

Conclusions:

  • Fluphenazine exhibits significant antimutagenic activity.
  • It can potentially prevent genotoxicity from specific mutagens like daunorubicin and benzo[a]pyrene.
  • Free radical scavenging is a likely mechanism underlying fluphenazine's protective effects.

Related Concept Videos